Philip R. Harper, 10% Owner at Aevi Genomic Medicine, Inc. (GNMX), bought 1,112,357 shares at $1.60 ($2.0M) on 2017-03-24, disclosed to the SEC on 2017-03-27.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.79 | 1,000,000 | $1.8M | 90.9% |
| 2 | $1.60 | 4,705 | $8K | 0.4% |
| 3 | $1.60 | 53,826 | $86K | 4.4% |
| 4 | $1.60 | 53,826 | $86K | 4.4% |
| Total | $1.77 avg | 1,112,357 | $2.0M | 100% |
| Filing → |
| GNMX | BUY | 2017-08-14 | $24K | — | Filing → |
| ACAS | SELL | 2015-12-04 | $1.1M | — | Filing → |
| ACAS | SELL | 2015-03-13 | $577K | — | Filing → |